Radiopharmaceutical Theranostics Market Top Players Review and Growth by Forecast to 2028

Nuclear medicine imaging is generally based on utilizing radioactive isotopes attached to specific molecules to examine biological processes, such as disease pathophysiology. These drugs can be administered orally, intravenously, or interstitially. Every radiopharmaceutical is designed to travel to a specific location in the body, and as soon as it reaches the site, it releases radioactive substances that kill the tumor cells. Radiopharmaceuticals can target various malignancies such as prostate cancer, heart disease, thyroid cancer, and others. These drugs can also be used as both therapies and diagnostics, known as ‘theranostics. ‘

“Global Radiopharmaceutical Theranostics Market Analysis to 2028″ is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the radiopharmaceutical theranostics market with detailed market segmentation by radioisotope, source, approach, application, end user, and geography. The report provides key statistics on the market status of the leading radiopharmaceutical theranostics market players and offers key trends and opportunities in the market.

Download PDF Sample Copy at:

https://www.theinsightpartners.com/sample/TIPRE00024328/

MARKET SEGMENTATION

• Based on radioisotope, the global radiopharmaceutical theranostics market is segmented into technetium-99, gallium-68, iodine-131, iodine-123, 18f, y-90, lutetium (lu) 177, copper (cu) 67, copper (cu) 64 and others.
• On the basis of source, the market is bifurcated into nuclear reactors and cyclotrons.
• On the basis of approach, the market is bifurcated into targeted therapeutic [Rx] and companion diagnostic [DX].
• Based on application, the market is segmented into oncology, cardiology and others.
•  On the basis of end-users, the market is bifurcated into hospitals, academic & research institutes and others.

MARKET DYNAMICS
Drivers:

•  Rise in the prevalence of cancer.
•  Increase in the availability of radioactive medicines by market players.
•  Rise in investments by key players for developing novel theranostics agents.
•  Rise in awareness of radiopharmaceuticals theranostics applications in disease treatment.

Restraints:

•  Stringent rules and regulations by the government.
•  Shortage of skilled professionals.

IMPACT OF COVID-19ON RADIOPHARMACEUTICAL THERANOSTICS MARKET

COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The COVID-19 pandemic has impacted the worldwide economy at various levels and has become a threat to global health. Due to the shutdown of manufacturing units, shortage in the supply of raw materials, and labor, there was a decline in the sales of market players. However, the radiopharmaceutical theranostics market stakeholders increased their R&D in nuclear medicine techniques, which was useful for functioning imaging of physiological processes at both cellular and molecular levels. Several advancements in radiolabeling methods also improved the radiopharmaceuticals accessibility for molecular imaging or radionuclide therapy, i.e., expected to surge the growth of the radiopharmaceutical theranostics market. Therefore, the pandemic has significantly affected the market’s development and increased its growth.

TOP PLAYERS

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the radiopharmaceutical theranostics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

•  Nihon Medi-Physics
•  Clarity Pharmaceuticals
•  Telix Pharmaceuticals
•  GE Healthcare
•  Theragnostics Ltd
•  ITM Isotopen Technologien München AG
•  Jubilant Pharma Limited
•  NuView Life Sciences
•  Lantheus Holdings, Inc.
•  Advanced Accelerator Applications

Have a Call with Analyst:

https://www.theinsightpartners.com/speak-to-analyst/TIPRE00024328/

About The Insight Partners:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876